MARKET

AKESF

AKESF

Akeso
OTCPK
14.10
NaN%
Closed 09:30 02/13 EST
OPEN
--
PREV CLOSE
12.72
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
22.70
52 WEEK LOW
8.37
MARKET CAP
12.99B
P/E (TTM)
-105.3812
1D
5D
1M
3M
1Y
5Y
1D
Bernstein Sticks to Their Hold Rating for Akeso, Inc. (9926)
TipRanks · 4d ago
Akeso Grants JumpCan Exclusive Mainland China Rights to Cholesterol Drug 伊喜寧®
TipRanks · 02/03 11:40
Summit spikes as lead asset undergoes FDA review
Seeking Alpha · 01/29 12:47
Akeso Details Long-Term MAb Contract Manufacturing and Demand Assumptions
TipRanks · 01/26 10:39
Akeso announces NMPA acceptance of second NDA for gumokimab
TipRanks · 01/19 20:15
Akeso's Cadonilimab Outperforms PD-1 Inhibitors In Gastric Cancer; Stock Up
NASDAQ · 01/14 11:17
Akeso Secures NMPA Label Update For Ivonescimab With Dual Survival Benefits In NSCLC
NASDAQ · 01/07 03:28
Akeso downgraded to Hold from Buy at Daiwa
TipRanks · 01/02 20:15
More
About AKESF
Akeso Inc is an investment holding company dedicated to the research, development, manufacturing and commercialization of antibody drugs that are affordable to patients worldwide. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The Company's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.

Webull offers Akeso Inc stock information, including OTCPK: AKESF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKESF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKESF stock methods without spending real money on the virtual paper trading platform.